Skip to Content

  • Search

View Additional Section Content

GOG-0230D – A Phase II Evaluation of Pazopanib (NSC #737754, IND #75648) in the Treatment of Recurrent or Persistent Carcinosarcoma of the Uterus

Clinical Trial Categories

  • Corpus Uterus/Sarcoma Cancer
Hanjani Institute for Gynecologic Oncology at 215-885-0220


  • Hanjani Institute for Gynecologic Oncology
    The Rosenfeld Cancer Center
    1200 Old York Rd, AMH - 1 Widener
    Abington, PA 19001
    Office: 215-885-0220
    Fax: 215-576-0740

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details